Expressable
PrivateLast Round
Series B
May 21, 2024
Est. Valuation
$55M
Total Funding Raised
$45.5M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Expressable is a healthcare technology company that provides an online speech therapy platform designed to enhance speech and language outcomes for both children and adults through various specialized services and weekly practice activities.
Sector
Healthcare & Life Sciences
Verticals
Telemedicine, Patient Engagement, Vertical SaaS
Business Model
B2B2C
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Expressable Comparables
Compare Expressable with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Great Speech, Inc. | 86% | |
| Huddle Up | 84% | |
| Better Speech | 81% |
Expressable Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | May 21, 2024 | ||||
| Series A | Feb 9, 2022 | ||||
| Seed | May 6, 2021 |
Key People
Founding team and executive leadership
Expressable Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Digitalis Ventures | Series B |
| F-Prime Capital | Series B, Series A |
| Amplifyher Ventures | Seed, Series A |
| NextView Ventures | Series A, Seed |
| HarbourVest Partners | Series B |
| F-Prime Capital | Series B, Series A |
| Lerer Hippeau | Series B, Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 1, 2026
Served thousands of clients since inception in late 2019.
- Apr 1, 2026
Achieved over 3,000 5-star reviews.
Expressable Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Expressable's valuation, stock price, and market status.
Is Expressable a public or private company?
Expressable is a private company.
What is the current stock price of Expressable?
Expressable is a private company with no public stock price. No recent secondary market data is available.
How much is Expressable worth (valuation)?
Expressable's valuation is estimated at $55.0M based on funding round data.
Can I buy Expressable stock?
Expressable shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Expressable's last funding round?
Expressable's most recent funding round was Series B on February 9, 2022.
Who are the main investors in Expressable?
Key investors in Expressable include F-Prime Capital, NextView Ventures, HarbourVest Partners, Lerer Hippeau.
Will Expressable IPO soon?
No public IPO plans have been announced for Expressable.
How can I track Expressable secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Expressable's secondary market activity and sign up for updates.